|Day Low/High||146.85 / 155.62|
|52 Wk Low/High||17.91 / 178.50|
UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.
You never want to be caught in a counter trend rally.
Don't forget, this is a very large company with a lot more than the vaccine going on.
I would argue that the pandemic has lasted just long enough to wipe out the little guy and let the bigger guys have the run of the joint.
My COVID vaccine eligibility actually began about a week before my symptoms began.
A buy-write makes sense here, but the premiums are tight, so I'd rather do a buy-ratio spread.
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
Here's my view on this space and where the money is to be made.
Let's look back at how the market reacted to COVID-19 one year ago, and the lessons we can learn.
COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?
Let's set out the case for stocks -- and which kind -- and whether you might want to pay down other debt first.
Plus, the efficacy rate of the still-pending Novavax Covid-19 vaccine against variants of the virus give reason for pause.
How does this all end? I don't know that it does end.
Should we care about Australia's central bank taking overtly aggressive action to reign in the long end of their yield curve? Yes, we should.
The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.
I want you to think about how quickly the long end of the U.S. Treasury curve is moving.
A year ago the stock market was flying high, only to plummet with the spread of a deadly, mysterious virus; this is the story of how it found a bottom.
As an early vaccinator I can tell you that you can make money from these strange things provided you do them before everybody gets the jab.
No matter what you want to call it -- there are plenty of reasons to be bullish right now.
The forces that benefited shares of companies such as Peloton Interactive and Clorox may not sustain them once the impact of the virus subsides.
The fact is that even if there is some compromise, the next fiscal stimulus package will be closer to $1.9 trillion than $600 billion.
Let's not kid ourselves that there is any longer some kind of relationship between price and value. Or fact and truth.
* He shoots, he scores - with NVAX (+65% or +$87/share) today Several subscribers have expressed disinterest and even snarkiness in The Smartest Trader in the World's positions -- others like to see his book on almost a daily basis. I posted this up...
Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.
The revenue and earnings beats are nice but that's not what really got me fired up.
Will the vaccine will be a game changer? The charts are giving indications that J&J is ready to run.